Compare IMNM & GIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMNM | GIS |
|---|---|---|
| Founded | 2006 | 1866 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 18.5B |
| IPO Year | 2020 | 2003 |
| Metric | IMNM | GIS |
|---|---|---|
| Price | $18.25 | $33.13 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 16 |
| Target Price | $32.80 | ★ $42.07 |
| AVG Volume (30 Days) | 1.2M | ★ 8.9M |
| Earning Date | 05-08-2026 | 03-18-2026 |
| Dividend Yield | N/A | ★ 7.08% |
| EPS Growth | ★ 51.40 | N/A |
| EPS | N/A | ★ 3.56 |
| Revenue | $6,941,000.00 | ★ $2,037,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,127.34 | N/A |
| P/E Ratio | ★ N/A | $9.32 |
| Revenue Growth | N/A | ★ 4.11 |
| 52 Week Low | $7.96 | $31.75 |
| 52 Week High | $27.65 | $54.18 |
| Indicator | IMNM | GIS |
|---|---|---|
| Relative Strength Index (RSI) | 37.11 | 43.11 |
| Support Level | $16.81 | $32.20 |
| Resistance Level | $19.16 | $34.49 |
| Average True Range (ATR) | 0.91 | 0.92 |
| MACD | -0.12 | 0.16 |
| Stochastic Oscillator | 11.10 | 42.77 |
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.
General Mills is a global packaged-food company that produces snacks, cereal, convenient meals, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Pillsbury, Betty Crocker, Blue Buffalo, and Haagen-Dazs. In fiscal 2025, 81% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. Although most of General Mills' products are sold through retail stores to consumers, the company also sells products to the foodservice channel and the commercial baking industry.